These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 4539608)
1. [Trasylol in the shock therapy. Its effects and their interpretation]. Haberland GL; Koslowski L; Matis P Med Welt; 1972 Aug; 23(31):1049-56. PubMed ID: 4539608 [No Abstract] [Full Text] [Related]
2. [Trasylol R on the status of experimental shock (preliminary results)]. Back N; Wilkens H; Munson AE; Steger R Rev Bras Med; 1968 Jun; 25(6):410-5. PubMed ID: 5304846 [No Abstract] [Full Text] [Related]
3. [Field study on the therapeutic value of trasylol in traumatic shock]. Schneider B; Schnells G; Trentz O; Tscherne H Chirurg; 1976 Apr; 47(4):185-8. PubMed ID: 1085692 [TBL] [Abstract][Full Text] [Related]
4. [Reactive fibrinolysis during heparin therapy in hemorrhagic-traumatic-and septic shock]. Popov-Cenić S; Dohmen M; Baymann E Med Welt; 1972 Feb; 23(7):221-4. PubMed ID: 5062328 [No Abstract] [Full Text] [Related]
5. [Early heparin administration in traumatic hemorrhagic shock? Study of patients with multiple injuries of various degrees of severity]. Sefrin P; Brunswig D; Wenzel M Med Welt; 1982 Apr; 33(17):638-41. PubMed ID: 7098827 [No Abstract] [Full Text] [Related]
6. [Results of a field study on the therapeutic value of aprotinin in traumatic shock (author's transl)]. Schneider B Arzneimittelforschung; 1976; 26(8):1606-10. PubMed ID: 795437 [TBL] [Abstract][Full Text] [Related]
7. [Hemorrhagic shock and proteinase inhibitor. Experimental analysis of the effects of this therapy on the ultrastructural lesions of the shock liver]. Mallet-Guy Y; Switalska C; Botev S; Mallet-Guy P J Chir (Paris); 1971 Apr; 101(4):361-76. PubMed ID: 5314385 [No Abstract] [Full Text] [Related]
9. Calcium antagonists in shock--a minireview of the evidence. Parratt JR Prog Clin Biol Res; 1989; 308():1065-74. PubMed ID: 2675039 [No Abstract] [Full Text] [Related]
10. The effects of ATP and a proteolytic enzyme inhibitor in irreversible shock. Massion WH; Erdos EG J Okla State Med Assoc; 1966 Aug; 59(8):467-71. PubMed ID: 5296339 [No Abstract] [Full Text] [Related]
11. [Effect of combined use of aprotinin and corticosteroid in traumatic shock rats (author's transl)]. Kugimiya H; Suemori I Masui; 1978 May; 27(5):484-9. PubMed ID: 307073 [No Abstract] [Full Text] [Related]
12. The absence of benefit of proteinase inhibition with aprotinin in severe shock in dogs. Smith JA; Norman JN Resuscitation; 1978; 6(4):249-58. PubMed ID: 314652 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of experimental hemorrhagic shock with a protease inhibitor: aprotinin]. Serrano JJ; Uccelli G; Liutkus M; Boucard M Therapie; 1979; 34(1):103-110. PubMed ID: 314684 [No Abstract] [Full Text] [Related]
14. [Heparin therapy in hemorrhagic traumatic shock]. Popov S; Dohmen M; Egli H Langenbecks Arch Chir; 1969; 325():60-6. PubMed ID: 5372375 [No Abstract] [Full Text] [Related]
15. [Intensive therapy of shock, especially using proteinase inhibitors]. Zimmerman WE Med Welt; 1975 Aug; 26(33-34):1478-9. PubMed ID: 1080829 [No Abstract] [Full Text] [Related]
16. [Proteinase inhibition in shock therapy. Colloquium September 7, 1973 at Cologne]. Matis P Med Welt; 1973 Dec; 24(49):1963-5. PubMed ID: 4544302 [No Abstract] [Full Text] [Related]
17. [Effect of the proteinase inhibitor (aprotinin) on the course of experimental burn shock]. Rybák M; Petz R; Jańecek J; Petáková M Cas Lek Cesk; 1976 Sep; 115(35):1067-71. PubMed ID: 1086136 [No Abstract] [Full Text] [Related]
18. [Treatment of the tourniquet syndrome with Trasylol]. Kristen H; Eigler FW; Stock W Langenbecks Arch Chir; 1969; 325():292-5. PubMed ID: 5309028 [No Abstract] [Full Text] [Related]
19. [Administration of digitalis glycosides in shock]. Ciesielski L; Bilski D; Rylski J Pol Przegl Chir; 1969 Aug; 41(8):1003-7. PubMed ID: 5824757 [No Abstract] [Full Text] [Related]